Literature DB >> 10590152

The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.

F Li1, C Leroux, J K Craigo, S J Cook, C J Issel, R C Montelaro.   

Abstract

Equine infectious anemia virus (EIAV) is genetically one of the simplest lentiviruses in that the viral genome encodes only three accessory genes, tat, rev, and S2. Although serological analyses demonstrate the expression of the S2 protein in persistently infected horses, the role of this viral gene remains undefined. We recently reported that the S2 gene is not essential for EIAV replication in primary equine macrophages, as EIAV mutants lacking the S2 gene replicate to levels similar to those of the parental virus (F. Li, B. A. Puffer, and R. C. Montelaro, J. Virol. 72:8344-8348, 1998). We now describe in vivo studies that examine the evolution and role of the S2 gene in ponies experimentally infected with EIAV. The results of these studies reveal for the first time that the S2 gene is highly conserved during persistent infection and that deletion of the S2 gene reduces viral virulence and virus replication levels compared to those of the parental virus containing a functional S2 gene. These data indicate that the EIAV S2 gene is in fact an important determinant of viral replication and pathogenic properties in vivo, despite the evident lack of S2 influence on viral replication levels in vitro. Thus, these observations suggest in vivo functions of EIAV S2 that are not adequately reflected in simple infections of cultured cells, including natural target macrophages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590152      PMCID: PMC111574          DOI: 10.1128/jvi.74.1.573-579.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  cDNA sequence of the env gene of a pathogenic equine infectious anemia lentivirus variant.

Authors:  T C McGuire; P A Lacy; K I O'Rourke
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

Review 3.  HIV accessory proteins: leading roles for the supporting cast.

Authors:  D Trono
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

4.  Nucleotide sequence analysis of equine infectious anemia virus proviral DNA.

Authors:  T Kawakami; L Sherman; J Dahlberg; A Gazit; A Yaniv; S R Tronick; S A Aaronson
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

5.  Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.

Authors:  D L Lichtenstein; K E Rushlow; R F Cook; M L Raabe; C J Swardson; G J Kociba; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.

Authors:  D C Sellon; K M Walker; K E Russell; S T Perry; P Covington; F J Fuller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.

Authors:  S M Lang; M Weeger; C Stahl-Hennig; C Coulibaly; G Hunsmann; J Müller; H Müller-Hermelink; D Fuchs; H Wachter; M M Daniel
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.

Authors:  R L Schiltz; D S Shih; S Rasty; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification.

Authors:  V M Hirsch; M E Sharkey; C R Brown; B Brichacek; S Goldstein; J Wakefield; R Byrum; W R Elkins; B H Hahn; J D Lifson; M Stevenson
Journal:  Nat Med       Date:  1998-12       Impact factor: 87.241

View more
  19 in total

1.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Authors:  Xu Qi; Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Rongxian Shen; Fenglong Wang; Xiangang Kong; Zhiqiang Su; Jianhua Zhou
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

4.  Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Authors:  Jodi K Craigo; Corin Ezzelarab; Ronald C Montelaro
Journal:  J Virol Methods       Date:  2012-07-20       Impact factor: 2.014

5.  Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.

Authors:  Sha Jin; Charles J Issel; Ronald C Montelaro
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

6.  S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.

Authors:  Ajit Chande; Emilia Cristiana Cuccurullo; Annachiara Rosa; Serena Ziglio; Susan Carpenter; Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-01       Impact factor: 11.205

7.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

8.  Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.

Authors:  Jörg Zielonka; Ignacio G Bravo; Daniela Marino; Elea Conrad; Mario Perković; Marion Battenberg; Klaus Cichutek; Carsten Münk
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

9.  Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.

Authors:  Daniel C Farley; Richard Bannister; Marie A Leroux-Carlucci; Nerys E Evans; James E Miskin; Kyriacos A Mitrophanous
Journal:  Hum Gene Ther Methods       Date:  2012-11-02       Impact factor: 2.396

10.  Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.

Authors:  Xin Yin; Zhe Hu; Qinyong Gu; Xingliang Wu; Yong-Hui Zheng; Ping Wei; Xiaojun Wang
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.